JP2015506949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506949A5 JP2015506949A5 JP2014554928A JP2014554928A JP2015506949A5 JP 2015506949 A5 JP2015506949 A5 JP 2015506949A5 JP 2014554928 A JP2014554928 A JP 2014554928A JP 2014554928 A JP2014554928 A JP 2014554928A JP 2015506949 A5 JP2015506949 A5 JP 2015506949A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- influenza virus
- vaccine
- influenza
- swine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000282887 Suidae Species 0.000 claims description 11
- 229960005486 vaccine Drugs 0.000 claims description 10
- 206010022000 influenza Diseases 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 2
- 241000725681 Swine influenza virus Species 0.000 claims 7
- 241000712461 unidentified influenza virus Species 0.000 claims 5
- 241000713297 Influenza C virus Species 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 3
- 241000282898 Sus scrofa Species 0.000 claims 2
- 230000003321 amplification Effects 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 201000010740 swine influenza Diseases 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000282339 Mustela Species 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 claims 1
- 208000037799 influenza C Diseases 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000003753 real-time PCR Methods 0.000 claims 1
- 238000010839 reverse transcription Methods 0.000 claims 1
- 230000007485 viral shedding Effects 0.000 claims 1
- 241000282412 Homo Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 238000010211 hemagglutination inhibition (HI) assay Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/385,004 | 2012-01-27 | ||
| US13/385,004 US9278999B2 (en) | 2012-01-27 | 2012-01-27 | Influenza C virus and vaccine |
| PCT/US2013/023441 WO2013112995A1 (en) | 2012-01-27 | 2013-01-28 | Influenza c virus and vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506949A JP2015506949A (ja) | 2015-03-05 |
| JP2015506949A5 true JP2015506949A5 (enExample) | 2017-03-09 |
| JP6257529B2 JP6257529B2 (ja) | 2018-01-10 |
Family
ID=47714564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014554928A Active JP6257529B2 (ja) | 2012-01-27 | 2013-01-28 | インフルエンザｃウイルス及びワクチン |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9278999B2 (enExample) |
| EP (1) | EP2807184A1 (enExample) |
| JP (1) | JP6257529B2 (enExample) |
| CN (1) | CN104203972A (enExample) |
| AU (1) | AU2013211833B2 (enExample) |
| BR (1) | BR112014018278B1 (enExample) |
| CA (1) | CA2862328C (enExample) |
| HK (1) | HK1201283A1 (enExample) |
| MX (1) | MX360831B (enExample) |
| NZ (1) | NZ629378A (enExample) |
| PH (1) | PH12014501688A1 (enExample) |
| RU (1) | RU2656186C2 (enExample) |
| WO (1) | WO2013112995A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015000789A (es) * | 2012-07-19 | 2015-05-07 | Zoetis Llc | Composiciones de virus de la gripe bovina. |
| AR111770A1 (es) | 2017-05-05 | 2019-08-21 | Elanco Us Inc | Vacuna para enfermedad respiratoria bovina |
| CN111363855A (zh) * | 2020-04-30 | 2020-07-03 | 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） | 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004161781A (ja) * | 1992-03-03 | 2004-06-10 | Dai Ichi Seiyaku Co Ltd | 経口ワクチン |
| AUPQ846900A0 (en) * | 2000-06-29 | 2000-07-27 | Aruba International Pty Ltd | A vaccine |
| CA2671869A1 (en) * | 2006-12-15 | 2008-06-26 | Schering-Plough Ltd. | Method for replicating influenza virus in culture |
| TW200927928A (en) | 2007-09-24 | 2009-07-01 | Nobilon Internat B V | Inactivated influenza vaccine |
| US20090110698A1 (en) * | 2007-10-31 | 2009-04-30 | Newport Laboratories, Inc. | Method of determining vaccine compliance |
| RU2428476C1 (ru) * | 2010-06-21 | 2011-09-10 | Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) | Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации |
-
2012
- 2012-01-27 US US13/385,004 patent/US9278999B2/en active Active
-
2013
- 2013-01-28 AU AU2013211833A patent/AU2013211833B2/en not_active Ceased
- 2013-01-28 CA CA2862328A patent/CA2862328C/en active Active
- 2013-01-28 NZ NZ629378A patent/NZ629378A/en not_active IP Right Cessation
- 2013-01-28 RU RU2014134850A patent/RU2656186C2/ru active
- 2013-01-28 CN CN201380012424.3A patent/CN104203972A/zh active Pending
- 2013-01-28 BR BR112014018278-7A patent/BR112014018278B1/pt active IP Right Grant
- 2013-01-28 JP JP2014554928A patent/JP6257529B2/ja active Active
- 2013-01-28 WO PCT/US2013/023441 patent/WO2013112995A1/en not_active Ceased
- 2013-01-28 MX MX2014009022A patent/MX360831B/es active IP Right Grant
- 2013-01-28 HK HK15101817.2A patent/HK1201283A1/xx unknown
- 2013-01-28 EP EP13704305.5A patent/EP2807184A1/en not_active Ceased
-
2014
- 2014-07-24 PH PH12014501688A patent/PH12014501688A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11993789B2 (en) | Pichinde virus reverse genetics systems and methods of use | |
| Chen et al. | Protection against multiple subtypes of influenza viruses by virus‐like particle vaccines based on a hemagglutinin conserved epitope | |
| Dong et al. | Promising MS2 mediated virus-like particle vaccine against foot-and-mouth disease | |
| CN103221064B (zh) | 抗流感病毒的免疫方法及其组合疫苗 | |
| Xu et al. | Immunogenicity of T7 bacteriophage nanoparticles displaying GH loop of foot-and-mouth disease virus (FMDV) | |
| Chen et al. | Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus | |
| Park et al. | Protective efficacy of crude virus‐like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy | |
| CN108456663A (zh) | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 | |
| Nogales et al. | Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use | |
| EP2716752A1 (en) | Canine influenza recombinant virus, preparation method therefor and application thereof | |
| JP2015506949A5 (enExample) | ||
| Yi et al. | Molecular characterization of a virulent genotype VIId strain of Newcastle disease virus from farmed chickens in Shanghai | |
| CN106381290B (zh) | 重组欧洲禽源h1n1亚型猪流感疫苗株及其制备方法和应用 | |
| WO2008145000A1 (en) | A foot-and-mouth disease virus double-effective vaccine vector, construction method and uses thereof | |
| Dong et al. | Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease | |
| Wu et al. | Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice | |
| Yang et al. | Rabbit Hemorrhagic Disease Virus Variant Recombinant VP60 Protein Induces Protective Immunogenicity. | |
| Rekstin et al. | Live attenuated influenza H7N3 vaccine is safe, immunogenic and confers protection in animal models | |
| RU2464312C1 (ru) | Реассортантный штамм вируса гриппа rn2/57-human a(h7n2) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации | |
| CN103881983B (zh) | 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗 | |
| RU2014134850A (ru) | Вирус гриппа с и вакцина | |
| Choi et al. | Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea | |
| Kim et al. | Preliminary study about sublingual administration of bacteria-expressed pandemic H1N1 influenza vaccine in miniature pigs | |
| Park et al. | Immunostained plaque assay for detection and titration of rabies virus infectivity | |
| Wang et al. | Construction of a novel porcine circovirus type 2 infectious clone as a basis for the development of a PCV2 iDNA vaccine |